Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hefti

Showing results (331-340 of 342) with videos related to

Pageof 35
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AW P Burkard, E P Bonetti, M Da Prada, et al.
Journal of Periodontology|May 12, 2000
Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitisJ G Caton, S G Ciancio, T M Blieden, et al.
Neurobiology of Aging|March 1, 1989
Potential use of nerve growth factor to treat Alzheimer's diseaseC H Phelps, F H Gage, J H Growdon, et al.
Journal of Clinical Periodontology|July 10, 2001
Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effectsJ G Caton, S G Ciancio, T M Blieden, et al.
Neuroreport|August 3, 2000
CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesionS J Harper, M S Saporito, L Hewson, et al.
Journal of Periodontology|October 1, 2004
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trialPhilip M Preshaw, Arthur F Hefti, M John Novak, et al.
Neuroscience|March 2, 1999
Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivoS Harper, J Bilsland, L Young, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivorsA H Krieg, F Hefti, B M Speth, et al.
Ciba Foundation Symposium|January 1, 1996
Development of neurotrophic factor therapy for Alzheimer's diseaseF Hefti, M P Armanini, K D Beck, et al.
Nature|July 4, 1996
Characterization of a multicomponent receptor for GDNFJ J Treanor, L Goodman, F de Sauvage, et al.
Pageof 35

Showing results (331-340 of 342) with videos related to

Sort By:
Pageof 35
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AW P Burkard, E P Bonetti, M Da Prada, et al.
Journal of Periodontology|May 12, 2000
Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitisJ G Caton, S G Ciancio, T M Blieden, et al.
Neurobiology of Aging|March 1, 1989
Potential use of nerve growth factor to treat Alzheimer's diseaseC H Phelps, F H Gage, J H Growdon, et al.
Journal of Clinical Periodontology|July 10, 2001
Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effectsJ G Caton, S G Ciancio, T M Blieden, et al.
Neuroreport|August 3, 2000
CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesionS J Harper, M S Saporito, L Hewson, et al.
Journal of Periodontology|October 1, 2004
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trialPhilip M Preshaw, Arthur F Hefti, M John Novak, et al.
Neuroscience|March 2, 1999
Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivoS Harper, J Bilsland, L Young, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivorsA H Krieg, F Hefti, B M Speth, et al.
Ciba Foundation Symposium|January 1, 1996
Development of neurotrophic factor therapy for Alzheimer's diseaseF Hefti, M P Armanini, K D Beck, et al.
Nature|July 4, 1996
Characterization of a multicomponent receptor for GDNFJ J Treanor, L Goodman, F de Sauvage, et al.
Pageof 35